CADMF - Chemesis International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.6869
-0.0331 (-4.59%)
At close: 3:54PM EDT
Stock chart is not supported by your current browser
Previous Close0.7200
Open0.6900
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.6736 - 0.7200
52 Week Range0.5990 - 1.7200
Volume64,108
Avg. Volume179,388
Market Cap52.514M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire

    Chemesis International Inc. Announces Results of VividGro LED Lighting Installation

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is proud to announce it has completed installation of VividGro LED lighting and environment controls at its Natural Ventures cultivation facility in Puerto Rico. The completion of the previously announced partnership allowed the Company to double its cultivation area and was able to significantly decrease its energy requirements and costs. Along with domestic production, the Company is continuing to expand operations for international distribution of hemp-based CBD products.

  • GlobeNewswire

    Chemesis International Inc. Enters into an Agreement to Purchase Three Dispensary Operations in Puerto Rico

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces that its subsidiary, Natural Ventures PR LLC (“Natural Ventures”), has entered into an agreement to purchase (the “Acquisition”) three cannabis dispensary operations (the “Dispensaries”) in Puerto Rico from Caribbean Green LLC (“Caribbean Green”) in exchange for $1.3 million USD in cash over 24 months. The Dispensaries are currently operating under the Caribbean Green brand and will generate approximately $3,600,000 USD in revenues for calendar 2019.

  • GlobeNewswire

    Chemesis International Inc. Receives Puerto Rico Hemp Cultivation & Production License

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is proud to announce its subsidiary, Natural Ventures, in conjunction with First Medical Cannabis LLC, (“First Medical”) through its previously announced partnership, has received one of the first hemp cultivation and processing licenses in Puerto Rico. The Company has now finished the climatization of seeds, and will begin planting an initial high potency hemp CBD crop in the coming weeks.

  • Benzinga

    An Extraordinary International Misunderstanding: The UN's International Narcotics Control Board's Cannabis Quotas Are Not What The Media Portrays

    On Aug. 20, the United Nations International Narcotics Control Board (“INCB”) announced that Colombia would be awarded a quota of 1.2 tons of cannabis oil for internal medicinal and scientific use. This substantially reduced number compares to the 2018 quota of 47 tons, which caused euphoria and champagne corks to fly from bottles throughout the LATAM Andes, all the way to Canadian stock exchanges. Colombian and international media (not surprisingly) announced that this new limited quota represented a “fatal blow” to its cannabis industry.

  • GlobeNewswire

    Chemesis International Inc. Provides Update on Rapid Dose

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is proud to announce its subsidiary, Natural Ventures, has completed the installation, permitting, and testing phase of its QuickStrip™ oral thin strip production equipment. The Company has completed the previously announced commercialization strategy, and has begun accepting orders for QuickStrip for immediate distribution across Puerto Rico and the United States. Since receiving Gold Vendor Status from Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) Chemesis has continued to work diligently to ensure the QuickStrip go to market strategy is done effectively and efficiently.

  • GlobeNewswire

    Chemesis International Inc. Completes Acquisition of Controlling Interest in GSRX Industries Inc., a Leader in Retail Cannabis Dispensaries, Distribution & Brand Development

    GSRX Industries is a vertically integrated cannabis company with multi-state operations and the largest medicinal cannabis dispensary network in Puerto Rico. The company has developed a retail focused approach and is currently expanding across the United States. VANCOUVER, British Columbia, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE:CSI) (CADMF) (CWAA.F) (the “Company” or “Chemesis”), is pleased to announce that it has completed its previously announced transaction  to acquire a controlling interest in GSRX Industries Inc. (“GSRX”) (OTCQB: GSRX) (the “Acquisition”), pursuant to which  the Company has acquired from certain former GSRX shareholders (the “Selling Shareholders”) an aggregate of [42,634,124] common shares and [1,000] preferred shares of GSRX, in exchange for an aggregate of [14,875,343] Chemesis common shares (“Chemesis Consideration Shares”).

  • GlobeNewswire

    Chemesis International Inc. Signs International Supply Agreement for CBD Products

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces it has received an initial purchase order for $1,100,000 USD for manufacturing CBD products. The purchase order is for CBD products that will be shipped to the United Kingdom (“UK”). The total current European cannabis market is estimated to be worth $68.5 billion USD, while the UK is projected to account for $4.6 billion USD of this market1.

  • GlobeNewswire

    Chemesis International Inc. Provides Update on Operations and GSRX Transaction

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces that it is continuing to proceed toward completing the previously announced transaction (“Acquisition”) to purchase a majority stake in GSRX Industries Inc. (“GSRX”) (OTCQB:GSRX), with an anticipated closing date of August 31, 2019. GSRX currently operates five dispensaries in Puerto Rico and has plans to open five additional dispensaries on the island. The company also operates one retail CBD kiosk in Clarksville, Tennessee with a retail store front expected to open up in Nashville, Tennessee as well as Lakeway, Texas.

  • GlobeNewswire

    Chemesis International Inc. to Begin Process of Obtaining NSF Facility Certification & Health Canada Certification for its Tobacco-Free Chew Products

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces it is in the process of obtaining NSF Certification for its facility to ensure the Company is able to market its products to consumers with NSF accreditation. Chemesis has engaged with a senior consultant that has a background in nutraceuticals as well as obtaining facility and product certifications. The mission of NSF International is to protect public health, a mission we share with regulatory agencies and personnel whose job is to do the same.

  • Benzinga

    Michigan's Cannabis Sector Is Emergent, Thanks To Favorable Legislation

    The US cannabis market, in general, has been opening up, especially since Canada legalized marijuana in late 2018. Despite the progress being slow, 11 states already allow the recreational use of marijuana. Medical marijuana is legal in 33 states.

  • GlobeNewswire

    Chemesis International Inc. Announces Letter of Intent for Canadian Distribution Agreement

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces that it has signed Letters of Intent (“LOIs”) with 34 private liquor stores in British Columbia (B.C.) for distribution of its hemp-based chew products, pursuant to which Chemesis expects to begin distributing its products throughout the lower mainland and other densely populated areas of B.C. by early Q4 2019. Chemesis anticipates strong demand in the Canadian market, as its tobacco-free, smokeless product is a healthier alternative to otherwise similar products that are currently available. Opportunities outside of liquor stores will also be pursued as the company gears towards its Q4 2019 commercialization.

  • GlobeNewswire

    Chemesis International Inc. to Introduce Tobacco-Free Smokeless Cannabis Chew

    Chemesis’ to bring manufacturing and distribution of tobacco-free, smokeless cannabis chew to the United States, Puerto Rico and Canada. VANCOUVER, British Columbia, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces that it will begin to manufacture, package and distribute its own line of tobacco-free smokeless cannabis and hemp derived chew with initial launch and commercialization in the United States, Puerto Rico and Canada. The Company continues to build out a unique portfolio of proprietary and patented delivery methods for cannabinoids, including THC and CBD.

  • GlobeNewswire

    Chemesis International Inc. to Acquire Controlling Interest in GSRX Industries Inc., a Leader in Retail Cannabis Dispensaries, Distribution & Brand Development

    GSRX Industries is a vertically integrated cannabis company with multi-state operations and the largest medicinal cannabis dispensary network in Puerto Rico. The company has developed a retail focused approach and is currently expanding across the United States. VANCOUVER, British Columbia, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces that it has entered into binding share exchange agreements (the “Share Exchange Agreements”) with certain shareholders (“Selling Shareholders”) of GSRX Industries Inc. (“GSRX”) (OTCQB: GSRX) (the “Acquisition”), pursuant to which the Company will acquire an aggregate of 42,634,124 common shares and 1,000 preferred shares of GSRX, in exchange for an aggregate of 18,915,738 Chemesis common shares to be issued to the Selling Shareholders (“Chemesis Consideration Shares”).

  • GlobeNewswire

    Chemesis International Inc. Provides Operational Update

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is pleased to provide operational and corporate updates for its operating entities in the United States, Puerto Rico and Colombia. GSRX has steadily increased revenues and continues to grow its dispensary network throughout Puerto Rico, California, Tennessee. Rapid Dose continues to work with Chemesis in its efforts to commercialize its QuickstripTM Oral Thin Strips in Puerto Rico, California and Michigan.

  • GlobeNewswire

    Chemesis International Inc. Announces Partnership with Happy Tea

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces a Partnership with U.S. based Happy Tea, a brand of CBD infused sachets and shots. This Partnership allows Happy Tea to expand its product offering and realize cost savings by leveraging Chemesis’ extraction, finished goods manufacturing and retail distribution. Happy Tea currently offers 3 products including powdered drink mixes and flavoured oil shots that are comprised of a blend of all-natural ingredients, antioxidants and are infused with 10mg of CBD.  Consumers can purchase these products individually or subscribe to monthly deliveries, which are shipped via the company’s e-commerce sales channels across the United States.

  • Benzinga

    From Coffee To Cannabis: Colombian Legislators To Move For Adult-Use Legalization

    This is the first of a two-part series on the history of Colombia and its route to cannabis legalization. Colombia is in an extraordinary position. It possesses the fourth largest economy in Latin America.

  • GlobeNewswire

    Chemesis International Inc. Announces $6,000,000 USD Annual Minimum Purchase Order with PR ONE for Dry Flower & Cannabis Infused Goods

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), through its subsidiary, Natural Ventures, announces it has signed an exclusive manufacturing agreement with PR ONE, a Puerto Rico based medical cannabis company. PR ONE’s flagship store is located in the San Juan Metro area and has over 6,000 ft2 of retail floor space. Natural Ventures will be PR ONE’s main manufacturer and will maintain a first right of refusal for future products and additional dispensaries.

  • Rapid Dose Therapeutics and Chemesis to Introduce Innovative QuickStrip™ Oral Thin Strips to the Michigan Cannabis Market
    PR Newswire

    Rapid Dose Therapeutics and Chemesis to Introduce Innovative QuickStrip™ Oral Thin Strips to the Michigan Cannabis Market

    BURLINGTON, ON and VANCOUVER, June 27, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. (CSE: DOSE), ("RDT") and Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the "Company") announced today that they have expanded the scope of their previously announced agreement (the "Agreement") expanding the territory where Chemesis has been granted Gold Vendor Status to license, manufacture, distribute and sell RDT's QuickStrip™ innovative, proprietary delivery technology for the medical cannabis market to Michigan, USA.

  • GlobeNewswire

    Chemesis International Inc. & Rapid Dose Therapeutics Sign Agreement to Bring QuickStrip™ Oral Thin Strips to Michigan

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), and Rapid Dose Therapeutics Inc. (“RDT”), are proud to announce they have signed an additional definitive agreement to bring QuickStrip™ Oral Thin Strips to the state of Michigan. The Company previously announced a definitive agreement to produce QuickStrips™ for the state of California and subsequently to bring QuickStrips™ to Puerto Rico.

  • GlobeNewswire

    Chemesis International Inc. Receives Approval from the State of Michigan to Initiate Construction of its Hemp Processing Facility

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces it has received approval from the State of Michigan to commence construction of its Hemp Processing facility (“Facility”). With this approval, the Company will continue to focus on obtaining assets that allow Chemesis’ to vertically integrate its operations in the state. Chemesis will also work to bring its existing partnerships and brands from its current portfolio to consumers in Michigan.

  • GlobeNewswire

    Chemesis International Inc. Receives Hemp Licensing in Central United States

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”) announces it has received its Hemp Cultivation & Processing Licenses (“Licenses”) in the state of Michigan. With these licenses, the Company will begin its initial planting process in the coming weeks. The Company will also continue to evaluate assets and apply for licensing in the previously announced states such as Wisconsin, Illinois, Missouri, and Michigan.

  • GlobeNewswire

    Chemesis International Inc. Begins Commercialization of QuickStrip™ Oral Thin Strips

    With the expanded manufacturing, Chemesis will launch distribution of the CBD QuickStrip™ Oral Thin Strips, to retailers across the United States. VANCOUVER, British Columbia, June 13, 2019 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces it has begun commercialization of QuickStrip™Oral Thin Strips. The Company will deliver CBD infused strips across the United States as well as THC & CBD infused strips in Puerto Rico.

  • GlobeNewswire

    Chemesis International Inc. Reports Fiscal Q3 2019 Financial Statements

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces unaudited fiscal Q3 Financial Statements for the three months ending March 31, 2019. Additionally, the Company has the option to expand to an additional 5,000 acres.

  • GlobeNewswire

    Chemesis International Inc. Receives Three Additional Cultivation Licenses & Begins Process to Increase Land Package by 10,000 Acres in Colombia

    Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), wholly owned subsidiary La Finca Interacviva-Arachna Med SAS (“La Finca”) announces it has received notification from the Ministry of Justice, that is has received approval for three new cultivation licenses for three additional farms located near Bogota, Colombia. Currently, the Company has 5 acres planted for its pilot spring harvest and has the ability to expand to over 100 acres once the initial harvest is complete.